|
1
|
Huvos AG: Bone Tumors: Diagnosis,
Treatment and Prognosis. WB Saunders; Philadelphia, PA: pp.
373–391. 1979
|
|
2
|
Unni KK: Dahlin’s Bone Tumors: General
Aspects and Data on 11,087 cases. 5th edition. Lippincott-Raven;
Philadelphia, PA: pp. 291–305. 1996
|
|
3
|
Chambers PW and Schwinn CP: Chordoma: A
clinicopathologic study of metastasis. Am J Clin Pathol.
72:765–776. 1979.PubMed/NCBI
|
|
4
|
Hruban RH, May M, Marcove RC and Huvos AG:
Lumbo-sacral chordoma with high-grade malignant cartilaginous and
spindle cell components. Am J Surg Pathol. 14:384–389. 1990.
View Article : Google Scholar
|
|
5
|
Coffin CM, Swanson PE, Wick MR and Dehner
LP: Chordoma in childhood and adolescence: A clinicopathologic
analysis of 12 cases. Arch Pathol Lab Med. 117:927–933.
1993.PubMed/NCBI
|
|
6
|
Kaneko Y, Sato Y, Iwaki T, Shin RW,
Tateishi J and Fukui M: Chordoma in early childhood: a
clincopathological study. Neurosurgery. 29:442–446. 1991.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Volpe R and Mazabraud A: A
clinicopathologic review of 25 cases of chordoma (a pleomorphic and
metastasizing neoplasm). Am J Surg Pathol. 7:161–170. 1983.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Osaka S, Kodoh O, Sugita H, Osaka E,
Yoshida Y and Ryu J: Clinical significance of a wide excision
policy for sacrococcygeal chordoma. J Cancer Res Clin Oncol.
132:213–218. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gennari L, Azzarelli A and Quagliuolo V: A
posterior approach for the excision of sacral chordoma. J Bone
Joint Surg Br. 69:565–568. 1987.PubMed/NCBI
|
|
10
|
Hulen CA, Temple HT, Fox WP, Sama AA,
Green BA and Eismont FJ: Oncologic and functional outcome following
sacrectomy for sacral chordoma. J Bone Joint Surg Am. 88:1532–1539.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Samson IR, Springfield DS, Suit HD and
Mankin HJ: Operative treatment of sacrococcygeal chordoma. A review
of twenty-one cases. J Bone Joint Surg Am. 75:1476–1484. 1993.
|
|
12
|
Fuchs B, Dickey ID, Yaszemski MJ, Inwards
CY and Sim FH: Operative management of sacral chordoma. J Bone
Joint Surg Am. 87:2211–2216. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Mirra JM, Rocca CD, Nelson SD and Mertens
F: Chordoma. World Health Organization Classification of Tumors.
Pathology and Genetics of Tumours of Soft Tissue and Bone. Fletcher
CDM: IARC Press; Lyon: pp. 316–317. 2002
|
|
14
|
Shinmura Y, Miura K, Yajima S and Tsutsui
Y: Sacrococcygeal chordoma in infancy showing an aggressive
clinical course: an autopsy case report. Pathol Int. 53:473–477.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Iwasa Y, Nakashima Y, Okajima H and
Morishita S: Sacral chordoma in early childhood:
clinicopathological and immunohistochemical study. Pediatr Dev
Pathol. 1:420–426. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hanna SA, Tirabosco R, Amin A, et al:
Dedifferentiated chordoma: a report of four cases arising ‘de
novo’. J Bone Joint Surg Br. 90:652–656. 2008.PubMed/NCBI
|
|
17
|
Murad TM and Murthy MS: Ultrastructure of
a chordoma. Cancer. 25:1204–1215. 1970. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Makek M and Leu HJ: Malignant fibrous
histiocytoma arising in a recurrent chordoma. Case report and
electron microscopic findings. Virchows Arch A Pathol Anat Histol.
397:241–250. 1982. View Article : Google Scholar
|
|
19
|
Scholzen T and Gerdes J: The Ki-67
protein: from the known and the unknown. J Cell Physiol.
182:311–322. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Holton JL, Steel T, Luxsuwong M, Crockard
HA and Revesz T: Skull base chordomas: correlation of the tumour
doubling time with age, mitosis and Ki67 proliferation index.
Neuropathol Appl Neurobiol. 26:497–503. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bergh P, Kindblom LG, Gunterberg B,
Remotti F, Ryd W and Meis-Kindblom JM: Prognostic factors in
chordoma of the sacrum and mobile spine: a study of 39 patients.
Cancer. 88:2122–2134. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Klingler L, Shooks J, Fiedler PN, Marney
A, Butler MG and Schwartz HS: Microsatellite instability in sacral
chordoma. J Surg Oncol. 73:100–103. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Horbinski C, Oakley GJ, Cieply K, et al:
The prognostic value of Ki-67, p53, epidermal growth factor
receptor, 1p36, 9p21, 10q23, and 17p13 in skull base chordomas.
Arch Pathol Lab Med. 134:1170–1176. 2010.PubMed/NCBI
|
|
24
|
York JE, Kaczaraj A, Abi-Said D, et al:
Sacral chordoma: 40-year experience at a major cancer center.
Neurosurgery. 44:74–80. 1999.PubMed/NCBI
|
|
25
|
Boriani S, Bandiera S, Biagini R, et al:
Chordoma of the mobile spine: fifty years of experience. Spine
(Phila Pa 1976). 31:493–503. 2006.PubMed/NCBI
|
